Home › Funds › Lincoln Financial › LVIP Loomis Sayles Global Growth Fund
Fund family: Lincoln Financial · Filed by LINCOLN VARIABLE INSURANCE PRODUCTS TRUST (CIK 914036) · SEC series S000061556
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 619 with, 58 against, 4 abstentions (not counted as with management); 22 items carried no recommendation. Shareholder proposals: 13 FOR, 51 AGAINST, 2 abstained, by the filing’s own vote-source field.
The same two figures as Lincoln Financial’s manager page (215,907 ballot items across 73 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Lincoln Financial | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 93.2% | 573 | 90.8% | 181,133 |
| Backed environmental and social shareholder proposals at US companies | n/a | 33 | 6.9% | 1,727 |
Each ballot item this fund voted is set against the votes of the other Lincoln Financial funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Lincoln Financial funds on 52 items (9.7% of the 534 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Lincoln Financial funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Meta Platforms, Inc. | 2026-05-27 | Shareholder A shareholder proposal regarding dual class capital structure. | Against | FOR — 16 of 16 Lincoln Financial funds | For | Not approved, 26.5% support |
| Alphabet Inc. | 2026-06-05 | Shareholder Shareholder proposal regarding equal shareholder voting | Against | FOR — 10 of 10 Lincoln Financial funds | For | Not approved, 31.2% support |
| Tesla, Inc. | 2025-11-06 | Shareholder A shareholder proposal to seek shareholder approval before adopting an amendment to the bylaws pursuant to Section 21.373 of the TBOC. | Against | FOR — 10 of 10 Lincoln Financial funds | For | Not approved, 49.4% support |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: John L. Hennessy | For | AGAINST — 7 of 7 Lincoln Financial funds | For | Elected, 85.2% support |
| Tesla, Inc. | 2025-11-06 | A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified: Ira Ehrenpreis | For | AGAINST — 7 of 7 Lincoln Financial funds | For | Elected, 65.0% support |
| Meta Platforms, Inc. | 2026-05-27 | Shareholder A shareholder proposal regarding annual vote regarding executive pay. | Against | FOR — 14 of 16 Lincoln Financial funds | For | Not approved, 27.1% support |
| Meta Platforms, Inc. | 2026-05-27 | Shareholder A shareholder proposal regarding disclosure of voting results by share class. | Against | FOR — 14 of 16 Lincoln Financial funds | For | Not approved, 20.1% support |
| Visa Inc. | 2026-01-27 | To approve amendments to our Eighth Restated Certificate of Incorporation to limit officer liability as permitted by Delaware Law. | Against | FOR — 10 of 11 Lincoln Financial funds | Against | Approved, 91.0% support |
| Sodexo SA | 2025-12-16 | Approve Remuneration Policy of Chairwoman of the Board, from November 10, 2025 | Against | FOR — 6 of 6 Lincoln Financial funds | Against | — |
| Tesla, Inc. | 2025-11-06 | Shareholder A shareholder proposal regarding proposal that won 54% support at 2024 Tesla annual meeting. | Against | FOR — 9 of 10 Lincoln Financial funds | For | Not approved, 32.3% support |
| Deere & Company | 2026-02-25 | Shareholder Shareholder proposal on shareholder right to act by written consent | For | AGAINST — 5 of 5 Lincoln Financial funds | Against | Not approved, 38.5% support |
| Yum! Brands, Inc. | 2026-05-14 | Shareholder Shareholder Proposal to Reduce the Percentage of Shares Required to Call a Special Meeting. | For | AGAINST — 5 of 5 Lincoln Financial funds | Against | Not approved, 37.7% support |
| CRISPR Therapeutics AG | 2026-06-04 | Re-election of Christian Rommel, Ph.D. | Against | FOR — 5 of 5 Lincoln Financial funds | Against | Elected, 98.2% support |
| CRISPR Therapeutics AG | 2026-06-04 | Re-election of Katherine A. High, M.D. | Against | FOR — 5 of 5 Lincoln Financial funds | Against | Elected, 98.2% support |
| CRISPR Therapeutics AG | 2026-06-04 | Re-election of Maria Fardis, Ph.D. | Against | FOR — 5 of 5 Lincoln Financial funds | Against | Elected, 98.2% support |
| CRISPR Therapeutics AG | 2026-06-04 | Re-election of Sandesh Mahatme, LL.M. | Against | FOR — 5 of 5 Lincoln Financial funds | Against | Elected, 95.1% support |
| Meta Platforms, Inc. | 2026-05-27 | Shareholder A shareholder proposal regarding report on addressing antisemitism and hate in online platforms. | For | AGAINST — 12 of 16 Lincoln Financial funds | Against | Not approved, 6.6% support |
| Tesla, Inc. | 2025-11-06 | A Tesla proposal for approval of the 2025 CEO Performance Award. | For | AGAINST — 8 of 10 Lincoln Financial funds | For | Approved, 77.0% support |
| Autodesk, Inc. | 2026-06-17 | Shareholder Stockholder proposal requesting amendment to stockholder special meeting right. | For | AGAINST — 6 of 7 Lincoln Financial funds | Against | Failed (calculated), 47.6% support |
| Autodesk, Inc. | 2026-06-17 | Approval of an amendment of our Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law. | Against | FOR — 6 of 7 Lincoln Financial funds | Against | Passed (calculated), 81.5% support |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: Andrew W. Houston | For | WITHHOLD — 7 of 9 Lincoln Financial funds | For | Elected, 91.1% support |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: Tony Xu | For | WITHHOLD — 7 of 9 Lincoln Financial funds | For | Elected, 91.2% support |
| Under Armour, Inc. | 2025-09-03 | Election of Directors: David W. Gibbs | Withhold | FOR — 3 of 3 Lincoln Financial funds | Against | Elected, 98.5% support |
| Under Armour, Inc. | 2025-09-03 | Election of Directors: Eugene D. Smith | Withhold | FOR — 3 of 3 Lincoln Financial funds | Against | Elected, 98.1% support |
| Under Armour, Inc. | 2025-09-03 | Election of Directors: Patrick W. Whitesell | Withhold | FOR — 3 of 3 Lincoln Financial funds | Against | Elected, 98.9% support |
| Company | Meeting | Item | This fund | Most Lincoln Financial funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| The Boeing Company | 2026-04-17 | Shareholder Action by Written Consent. | For | AGAINST — 6 of 8 Lincoln Financial funds | Against | Failed (calculated), 39.7% support |
| Tesla, Inc. | 2025-11-06 | A Tesla proposal for a non-binding advisory vote approving 2024 executive compensation. | For | AGAINST — 7 of 10 Lincoln Financial funds | For | Approved, 78.7% support |
| Tesla, Inc. | 2025-11-06 | A Tesla proposal for approval of the A&R 2019 Equity Incentive Plan. | For | AGAINST — 7 of 10 Lincoln Financial funds | For | Approved, 79.1% support |
| CRISPR Therapeutics AG | 2026-06-04 | Re-election of Douglas A. Treco, Ph.D. | Against | FOR — 4 of 5 Lincoln Financial funds | Against | Elected, 91.1% support |
| CRISPR Therapeutics AG | 2026-06-04 | Re-election of Simeon J. George, M.D. | Against | FOR — 4 of 5 Lincoln Financial funds | Against | Elected, 97.5% support |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: Frances H. Arnold | For | AGAINST — 5 of 7 Lincoln Financial funds | For | Elected, 90.1% support |
| Tesla, Inc. | 2025-11-06 | A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified: Kathleen Wilson-Thompson | For | AGAINST — 5 of 8 Lincoln Financial funds | For | Elected, 78.4% support |
| Oracle Corporation | 2025-11-18 | Advisory Vote to Approve the Compensation of our Named Executive Officers | For | AGAINST — 6 of 10 Lincoln Financial funds | For | Passed (calculated), 81.9% support |
| Oracle Corporation | 2025-11-18 | Election of Directors: Bruce R. Chizen | For | WITHHOLD — 4 of 6 Lincoln Financial funds | For | Elected, 76.1% support |
| Doximity, Inc. | 2025-08-28 | To elect two Class I Directors to serve until the annual meeting of stockholders to be held in 2028 or until their successors are duly elected and qualified: Jeffrey Tangney | For | WITHHOLD — 4 of 6 Lincoln Financial funds | For | Elected, 97.0% support |
| Alphabet Inc. | 2026-06-05 | Shareholder Shareholder proposal regarding a report on AI data usage oversight | Against | FOR — 5 of 9 Lincoln Financial funds | For | Not approved, 12.3% support |
| Alphabet Inc. | 2026-06-05 | Approval of the amendment and restatement of Alphabet's Amended and Restated 2021 Stock Plan to increase the share reserve by 200,000,000 shares of Class C capital stock | For | AGAINST — 5 of 9 Lincoln Financial funds | For | Approved, 90.4% support |
| QUALCOMM Incorporated | 2026-03-17 | Shareholder Stockholder proposal entitled "Shareholder Ability to Call for a Special Meeting." | Against | FOR — 5 of 9 Lincoln Financial funds | For | Not approved, 42.2% support |
| Shopify Inc. | 2026-06-16 | Elect Director Joseph (Joe) Natale | For | AGAINST — 3 of 5 Lincoln Financial funds | For | Elected, 90.4% support |
| CRISPR Therapeutics AG | 2026-06-04 | Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan. | For | AGAINST — 3 of 5 Lincoln Financial funds | For | Approved, 88.1% support |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027. | For | AGAINST — 3 of 5 Lincoln Financial funds | For | — |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026. | For | AGAINST — 3 of 5 Lincoln Financial funds | For | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Lars Rebien Sorensen (Chair) as New Director | For | ABSTAIN — 3 of 5 Lincoln Financial funds | — | — |
| Ferrari NV | 2026-04-15 | Reelect John Elkann as Executive Director | For | AGAINST — 3 of 5 Lincoln Financial funds | For | — |
| Arm Holdings Plc | 2025-09-09 | Approve Remuneration Report | For | AGAINST — 2 of 3 Lincoln Financial funds | For | — |
| Arm Holdings Plc | 2025-09-09 | Elect Jeffrey A. Sine as Director | For | AGAINST — 2 of 3 Lincoln Financial funds | For | — |
| Arm Holdings Plc | 2025-09-09 | Elect Masayoshi Son as Director | For | AGAINST — 2 of 3 Lincoln Financial funds | For | — |
| Arm Holdings Plc | 2025-09-09 | Elect Rene Haas as Director | For | AGAINST — 2 of 3 Lincoln Financial funds | For | — |
| Arm Holdings Plc | 2025-09-09 | Elect Ronald D. Fisher as Director | For | AGAINST — 2 of 3 Lincoln Financial funds | For | — |
| Under Armour, Inc. | 2025-09-03 | Election of Directors: Carolyn N. Everson | For | WITHHOLD — 2 of 3 Lincoln Financial funds | For | Elected, 92.7% support |
| Under Armour, Inc. | 2025-09-03 | Election of Directors: Eric T. Olson | For | WITHHOLD — 2 of 3 Lincoln Financial funds | For | Elected, 89.8% support |
| Under Armour, Inc. | 2025-09-03 | Election of Directors: Kevin A. Plank | For | WITHHOLD — 2 of 3 Lincoln Financial funds | For | Elected, 93.8% support |
Download all 52 differences (CSV)
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 383 | 0 |
| Corporate Governance | 73 | 18 |
| Capital Structure | 65 | 0 |
| Compensation | 63 | 2 |
| Audit-related | 48 | 0 |
| Say-on-Pay | 26 | 0 |
| Other Social Issues | 20 | 18 |
| Environment or Climate | 11 | 10 |
| Other | 6 | 0 |
| Human Rights or Human Capital/workforce | 5 | 5 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | May 13, 2026 | $70M | 14 | 0 |
| Meta Platforms, Inc. | May 27, 2026 | $33M | 22 | 9 |
| Alphabet Inc. | June 5, 2026 | $17M | 23 | 10 |
| Amazon.com, Inc. | May 20, 2026 | $16M | 17 | 0 |
| Tesla, Inc. | November 6, 2025 | $14M | 16 | 7 |
| Salesforce, Inc. | May 28, 2026 | $11M | 18 | 1 |
| Visa Inc. | January 27, 2026 | $10M | 18 | 4 |
| Alnylam Pharmaceuticals, Inc. | May 20, 2026 | $10M | 5 | 4 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | Against | For |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposal | Against | For |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding a report on water usage and AI development Shareholder proposal | Against | For |
| November 6, 2025 | Tesla, Inc. | A shareholder proposal regarding adopting targets and reporting on metrics to assess the feasibility of integrating sustainability metrics into senior executive compensation plans. Shareholder proposal | Against | For |
| November 6, 2025 | Tesla, Inc. | A shareholder proposal requesting a child labor audit. Shareholder proposal | Against | For |
| May 28, 2026 | Salesforce, Inc. | A stockholder proposal requesting the adoption of cumulative voting for director elections, if properly presented at the meeting. Shareholder proposal | Against | For |
| January 27, 2026 | Visa Inc. | Shareholder proposal requesting the Board of Directors to adopt a policy for an independent chair. Shareholder proposal | Against | For |
| January 27, 2026 | Visa Inc. | Shareholder proposal on shareholder right to act by written consent. Shareholder proposal | Against | For |
| May 20, 2026 | Alnylam Pharmaceuticals, Inc. | SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposal | Against | For |
| May 20, 2026 | Alnylam Pharmaceuticals, Inc. | SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
705 ballot items at 46 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, LVIP Loomis Sayles Global Growth Fund voted at 46 shareholder meetings of 44 companies, on 705 ballot items in all. Where management made a recommendation, the fund followed it on 90.9% of the items and voted against it 58 times. Its most frequent area of disagreement was corporate governance (18 of its votes against management). It voted FOR 20.3% of the 64 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Lincoln Financial's funds as a whole (93.2% against 90.8%). It voted differently from most Lincoln Financial funds on 52 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Lincoln Financial’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.